Patricia Fast

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Melissa Simek, Wasima Rida, Frances Priddy et al. · Journal of Virology · 2009 · 581 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 413 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

Angela Huttner, Julie-Anne Dayer, Sabine Yerly et al. · The Lancet Infectious Diseases · 2015 · 278 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

A human protein specific for the immunoglobulin octamer DNA motif contains a functional homeobox domain

H S Ko, Patricia Fast, Wesley O. McBride et al. · Cell · 1988 · 233 citations

Life Sciences, Genetics, Molecular Biology +15

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

Enoch Muyanja, Aloysius Ssemaganda, Pearline Ngauv et al. · Journal of Clinical Investigation · 2014 · 223 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14